US2021093072A1PendingUtilityA1
System for targeted application of topical agents to an isolated body part
Assignee: JOHNSON & JOHNSON CONSUMER INCPriority: Dec 22, 2016Filed: Oct 20, 2020Published: Apr 1, 2021
Est. expiryDec 22, 2036(~10.4 yrs left)· nominal 20-yr term from priority
A61K 8/02A61Q 19/00A45D 44/00A61M 35/10A45D 40/30A61K 2800/87A45D 44/002A61K 8/0212B33Y 10/00B33Y 80/00B32B 38/10B32B 7/06A61K 8/368A61P 17/10B44C 3/02A61K 8/0241
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A system includes an applicator mask having an applicator surface having a three-dimensional shape corresponding to the isolated body part; and at least one membrane releasably disposed on the applicator surface and having an outer surface in facing relation with the applicator surface and inner adhesive surface opposite thereof. The membrane includes one or more benefit agents disposed in one or more treatment zones.
Claims
exact text as granted — not AI-modified1 .- 10 . (canceled)
11 . A system for targeted application of topical agents to an isolated body part comprising:
(a) an applicator mask having an applicator surface having a three-dimensional shape configured to cover and to contact a corresponding contoured surface area of the isolated body part; and (b) a membrane releasably disposed on the applicator surface and having adhesive properties and an outer surface in facing relation with the applicator surface and inner adhesive surface opposite thereof, the membrane comprising one or more benefit agents disposed in one or more treatment zones wherein the releasable membrane is pre-configured to cover and contact the contoured surface of the isolated body part and the adhesion of the membrane to the isolated body part is greater than the adhesion of the membrane to the applicator surface, and at least one of the one or more benefit agents disposed in at least one of the has one or more treatment zones has a lower concentration proximate edges to the treatment zone.
12 . A system for targeted application of topical agents to an isolated body part comprising:
(a) an applicator mask having an applicator surface having a three-dimensional shape configured to cover and to contact a corresponding contoured surface area of the isolated body part; and (b) a stack of membranes releasably disposed on the applicator surface from a releasable membrane adhered to the applicator surface to an exposed releasable membrane, each releasable membrane having adhesive properties and comprising one or more benefit agents disposed in one or more treatment zones wherein the releasable membranes are pre-configured to cover and contact the contoured surface of the isolated body part and the adhesion of the exposed releasable membrane to the isolated body part is greater than the adhesion of the releasable membrane to the applicator surface and to a releasable membrane disposed adjacent to the exposed releasable membrane in the stack.
13 . The system of claim 12 wherein each of the plurality of releasable membranes further comprises the one or more benefit agents.
14 . The system of claim 12 wherein at least two of the plurality of releasable membranes are substantially identical.
15 . The system of claim 12 wherein one of the plurality of releasable membranes comprises at least one benefit agent that differs from the one or more benefit agents in an adjacent releasable membrane.
16 . The system of claim 12 wherein at least one of the one or more benefit agents disposed in at least one of the has one or more treatment zones has a lower concentration proximate edges to the treatment zone.
17 . The system of claim 12 wherein the isolated body part is the face.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.